446 related articles for article (PubMed ID: 30670444)
1. The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes.
Sallman DA; List A
Blood; 2019 Mar; 133(10):1039-1048. PubMed ID: 30670444
[TBL] [Abstract][Full Text] [Related]
2. The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype.
Basiorka AA; McGraw KL; Eksioglu EA; Chen X; Johnson J; Zhang L; Zhang Q; Irvine BA; Cluzeau T; Sallman DA; Padron E; Komrokji R; Sokol L; Coll RC; Robertson AA; Cooper MA; Cleveland JL; O'Neill LA; Wei S; List AF
Blood; 2016 Dec; 128(25):2960-2975. PubMed ID: 27737891
[TBL] [Abstract][Full Text] [Related]
3. Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes.
Ward GA; Dalton RP; Meyer BS; McLemore AF; Aldrich AL; Lam NB; Onimus AH; Vincelette ND; Trinh TL; Chen X; Calescibetta AR; Christiansen SM; Hou HA; Johnson JO; Wright KL; Padron E; Eksioglu EA; List AF
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835307
[TBL] [Abstract][Full Text] [Related]
4. Cellular senescence induced by S100A9 in mesenchymal stromal cells through NLRP3 inflammasome activation.
Shi L; Zhao Y; Fei C; Guo J; Jia Y; Wu D; Wu L; Chang C
Aging (Albany NY); 2019 Nov; 11(21):9626-9642. PubMed ID: 31727865
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype.
Sallman DA; Cluzeau T; Basiorka AA; List A
Front Oncol; 2016; 6():151. PubMed ID: 27379212
[TBL] [Abstract][Full Text] [Related]
6. SOHO State of the Art Update and Next Questions: Biology and Treatment of Myelodysplastic Syndromes.
Sallman DA; Tanaka TN; List A; Bejar R
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):613-620. PubMed ID: 29025689
[TBL] [Abstract][Full Text] [Related]
7. Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes.
Ward GA; McGraw KL; Abbas-Aghababazadeh F; Meyer BS; McLemore AF; Vincelette ND; Lam NB; Aldrich AL; Al Ali NH; Padron E; Pinilla-Ibarz J; Masala E; Santini V; Kosmider O; Fontenay M; Fenaux P; Johnson J; Fridley BL; List AF
Blood Adv; 2021 Apr; 5(8):2216-2228. PubMed ID: 33890980
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 inflammasome activation mediates radiation-induced pyroptosis in bone marrow-derived macrophages.
Liu YG; Chen JK; Zhang ZT; Ma XJ; Chen YC; Du XM; Liu H; Zong Y; Lu GC
Cell Death Dis; 2017 Feb; 8(2):e2579. PubMed ID: 28151471
[TBL] [Abstract][Full Text] [Related]
9. Somatic gene mutations expose cytoplasmic DNA to co-opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromes.
McLemore AF; Hou HA; Meyer BS; Lam NB; Ward GA; Aldrich AL; Rodrigues MA; Vedder A; Zhang L; Padron E; Vincelette ND; Sallman DA; Abdel-Wahab O; List AF; McGraw KL
JCI Insight; 2022 Aug; 7(15):. PubMed ID: 35788117
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of the inflammasome in myeloid malignancies.
Chakraborty S; Shapiro LC; de Oliveira S; Rivera-Pena B; Verma A; Shastri A
Blood Cancer J; 2021 Sep; 11(9):152. PubMed ID: 34521810
[TBL] [Abstract][Full Text] [Related]
11. UFL1 modulates NLRP3 inflammasome activation and protects against pyroptosis in LPS-stimulated bovine mammary epithelial cells.
Li C; Wang X; Kuang M; Li L; Wang Y; Yang F; Wang G
Mol Immunol; 2019 Aug; 112():1-9. PubMed ID: 31078114
[TBL] [Abstract][Full Text] [Related]
12. U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes.
Zhu Y; Song D; Guo J; Jin J; Tao Y; Zhang Z; Xu F; He Q; Li X; Chang C; Wu L
Cell Death Dis; 2021 Jun; 12(7):655. PubMed ID: 34183647
[TBL] [Abstract][Full Text] [Related]
13. [Research Progress on the Role of Pyroptosis in the Pathogenesis of Myelodysplastic Syndrome -Review].
Lin Y; Gao QP; Ye BX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):937-941. PubMed ID: 29950247
[TBL] [Abstract][Full Text] [Related]
14. Trimethylamine-N-Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3-SOD2-mtROS Signaling Pathway.
Chen ML; Zhu XH; Ran L; Lang HD; Yi L; Mi MT
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28871042
[TBL] [Abstract][Full Text] [Related]
15. Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy.
Vaxevanis CK; Bauer M; Subbarayan K; Friedrich M; Massa C; Biehl K; Al-Ali HK; Wickenhauser C; Seliger B
Oncoimmunology; 2023; 12(1):2152998. PubMed ID: 36531688
[TBL] [Abstract][Full Text] [Related]
16. The Nlrp3 inflammasome as a "rising star" in studies of normal and malignant hematopoiesis.
Ratajczak MZ; Bujko K; Cymer M; Thapa A; Adamiak M; Ratajczak J; Abdel-Latif AK; Kucia M
Leukemia; 2020 Jun; 34(6):1512-1523. PubMed ID: 32313108
[TBL] [Abstract][Full Text] [Related]
17. Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome.
Sun L; Ma W; Gao W; Xing Y; Chen L; Xia Z; Zhang Z; Dai Z
Cell Death Dis; 2019 Jul; 10(8):542. PubMed ID: 31316052
[TBL] [Abstract][Full Text] [Related]
18. The intersection of cell death and inflammasome activation.
Vince JE; Silke J
Cell Mol Life Sci; 2016 Jun; 73(11-12):2349-67. PubMed ID: 27066895
[TBL] [Abstract][Full Text] [Related]
19. Acinetobacter baumannii outer membrane protein 34 elicits NLRP3 inflammasome activation via mitochondria-derived reactive oxygen species in RAW264.7 macrophages.
An Z; Su J
Microbes Infect; 2019; 21(3-4):143-153. PubMed ID: 30439507
[TBL] [Abstract][Full Text] [Related]
20. Stressing out the mitochondria: Mechanistic insights into NLRP3 inflammasome activation.
Yabal M; Calleja DJ; Simpson DS; Lawlor KE
J Leukoc Biol; 2019 Feb; 105(2):377-399. PubMed ID: 30589456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
